Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1997 1
1998 2
2000 1
2001 2
2005 1
2006 2
2007 1
2008 4
2009 2
2010 2
2011 3
2012 2
2013 1
2014 1
2015 1
2016 3
2017 2
2018 4
2019 1
2020 7
2021 2
2022 4
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy.
Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, Sher X, Liu XQ, Lu H, Nebozhyn M, Zhang C, Lunceford JK, Joe A, Cheng J, Webber AL, Ibrahim N, Plimack ER, Ott PA, Seiwert TY, Ribas A, McClanahan TK, Tomassini JE, Loboda A, Kaufman D. Cristescu R, et al. Among authors: webber al. Science. 2018 Oct 12;362(6411):eaar3593. doi: 10.1126/science.aar3593. Science. 2018. PMID: 30309915 Free PMC article.
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
Zhu AX, Finn RS, Edeline J, Cattan S, Ogasawara S, Palmer D, Verslype C, Zagonel V, Fartoux L, Vogel A, Sarker D, Verset G, Chan SL, Knox J, Daniele B, Webber AL, Ebbinghaus SW, Ma J, Siegel AB, Cheng AL, Kudo M; KEYNOTE-224 investigators. Zhu AX, et al. Among authors: webber al. Lancet Oncol. 2018 Jul;19(7):940-952. doi: 10.1016/S1470-2045(18)30351-6. Epub 2018 Jun 3. Lancet Oncol. 2018. PMID: 29875066 Clinical Trial.
The functional impact of amblyopia.
Webber AL. Webber AL. Clin Exp Optom. 2018 Jul;101(4):443-450. doi: 10.1111/cxo.12663. Epub 2018 Feb 26. Clin Exp Optom. 2018. PMID: 29484704 Free article. Review.
Biomarkers predictive of response to pembrolizumab in head and neck cancer.
Pfister DG, Haddad RI, Worden FP, Weiss J, Mehra R, Chow LQM, Liu SV, Kang H, Saba NF, Wirth LJ, Sukari A, Massarelli E, Ayers M, Albright A, Webber AL, Mogg R, Lunceford J, Huang L, Cristescu R, Cheng J, Seiwert TY, Bauml JM. Pfister DG, et al. Among authors: webber al. Cancer Med. 2023 Mar;12(6):6603-6614. doi: 10.1002/cam4.5434. Epub 2022 Dec 7. Cancer Med. 2023. PMID: 36479637 Free PMC article.
Ocular manifestations of systemic diseases in children.
Chong C, Webber AL, Dai S. Chong C, et al. Among authors: webber al. Clin Exp Optom. 2023 Apr;106(3):238-248. doi: 10.1080/08164622.2022.2048999. Epub 2022 Mar 16. Clin Exp Optom. 2023. PMID: 35296228 Review.
Effects of simulated anisometropia and aniseikonia on stereopsis.
Atchison DA, Lee J, Lu J, Webber AL, Hess RF, Baldwin AS, Schmid KL. Atchison DA, et al. Among authors: webber al. Ophthalmic Physiol Opt. 2020 May;40(3):323-332. doi: 10.1111/opo.12680. Epub 2020 Mar 3. Ophthalmic Physiol Opt. 2020. PMID: 32128857
54 results